Erschienen in:
01.10.2012 | Clinical Trials and Their Interpretations (J Plutzky, Section Editor)
Evolving Concepts of Oxidative Stress and Reactive Oxygen Species in Cardiovascular Disease
verfasst von:
Kai Chen, John F. Keaney Jr.
Erschienen in:
Current Atherosclerosis Reports
|
Ausgabe 5/2012
Einloggen, um Zugang zu erhalten
Abstract
Cardiovascular disease (CVD) continues to be a substantial health-care burden, despite recent treatment advances. Oxidative stress has long been regarded as a key pathophysiological mediator that ultimately leads to CVD including atherosclerosis, hypertension and heart failure. Over the past decade, emerging evidence has shifted our understanding of reactive oxygen species (ROS) from its harmful role to being signaling molecules. Here, we reviewed recent advances in our understanding of ROS that mediate the complex process of CVDs, with a focus on major ROS signaling and sources such as mitochondria and Nicotinamide Adenine Dinucleotide Phosphate (NADPH) oxidases.